Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson's second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical ...
Zacks.com on MSN1d
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to KnowMcKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...
Fintel on MSN6d
Baird Upgrades McKesson (MCK)Fintel reports that on November 7, 2024, Baird upgraded their outlook for McKesson (NYSE:MCK) from Neutral to Outperform. ...
McKesson’s payout ratio is currently 14.71%. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical ...
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments ...
Attorneys for several prominent companies spoke to a capacity crowd during an Oct. 8 luncheon at the Hyatt Regency in ...
Telephone and Data Systems, Inc. (NYSE: TDS) is pleased to announce its Board of Directors has elected Napoleon B. Rutledge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback